POOLBEG PHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.8 GBX | 0.00% |
|
-5.88% | +41.44% |
| 05-01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
| 05-01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
Chart calendar Poolbeg Pharma PLC
aa305dd445959668bc5d871e890891f.fthKcGDiYNsT-PjASWl-LrIxpZ_MKbR7qlhY3FivCpE.EpMDL1bVKYhhqci4GQwpHOh_xt2OcMcp7RQTijv-Yvw1vCgSJ9oYvHGxkw~162d2949fec504dffc449781fcb10c69
Upcoming events on Poolbeg Pharma PLC
Past events on Poolbeg Pharma PLC
| 2024-04-30 13:00 | Business Update Call |
| 2024-04-30 02:00 | Q4 2023 Earnings Release |
| 2024-01-17 13:00 | Business Update Call |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-09 20:30 | American Society of Hematology Meeting |
| 2023-12-01 05:00 | International Immunology Congress |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-10 07:30 | Investor Meeting |
| 2023-11-06 09:00 | Investor Meeting |
| 2023-11-05 | Bio-Europe Conference |
| 2023-10-24 | ShareSoc Investor Webinar |
| 2023-10-16 | World Vaccine Congress |
| 2023-09-20 07:30 | Master Investor Sector Focus Healthcare Conference |
| 2023-09-13 02:00 | Q2 2023 Earnings Release |
| 2023-06-04 | BIO International Convention |
| 2023-05-13 | BioEquity Europe Conference |
| 2023-05-11 07:00 | Annual General Meeting |
| 2023-05-02 | LSX World Congress |
| 2023-04-24 | BioTrinity Conference |
| 2023-04-19 | Anglonordic Life Science Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 |
|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 | -4,96 -6,15 19.35% | -4,66 -5,74 18.75% |
|
EBIT Million GBP | Released Forecast Spread | 0,00 | -4,99 -6,18 19.34% | -4,69 -5,84 19.76% |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | 0,00 | -4,78 -6,60 27.62% | -4,51 -5,60 19.55% |
|
Net income Million GBP | Released Forecast Spread | -2,34 | -4,69 -6,60 29% | -3,93 -5,60 29.8% |
|
EPS GBP | Released Forecast Spread | -0,01 | -0,01 -0,01 24.68% | -0,01 -0,01 28.18% |
| Announcement Date | 02/03/22 | 30/03/23 | 30/04/24 |
More events
Past sector events for Poolbeg Pharma PLC
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 16:01 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- POLB Stock
- Calendar Poolbeg Pharma PLC
